Literature DB >> 8322451

Cathepsin-D expression in cervical carcinoma and its prognostic significance.

K M Mitchell1, R J Hale, C H Buckley, H Fox, D Smith.   

Abstract

An immunohistochemical study was made of cathepsin-D protein expression in each of the three main types of uterine cervical carcinoma (squamous carcinoma, adenosquamous carcinoma and adenocarcinoma) with particular reference to lymph node status and prognosis. Of the 61 cases, 54.1% showed cytoplasmic staining in more than 2.5% of tumour cells counted. Cathepsin-D expression was significantly higher in adenocarcinoma (mean -3.128) than in squamous carcinoma and adenosquamous carcinoma (mean -3.709, p = 0.047 using logit transformation). Cathepsin-D had no prognostic value in any of the three tumour types. No relationship was found between cathepsin-D staining and lymph node status and there was no advantage in adding cathepsin-D values to lymph node status. These results suggest that immunostaining for cathepsin-D protein expression is unlikely to be of use as a prognostic marker.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8322451     DOI: 10.1007/bf01605453

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  11 in total

1.  Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma.

Authors:  T Nazeer; J H Malfetano; T G Rosano; J S Ross
Journal:  Am J Clin Pathol       Date:  1992-06       Impact factor: 2.493

2.  Cathepsin D: an independent prognostic factor for metastasis of breast cancer.

Authors:  F Spyratos; T Maudelonde; J P Brouillet; M Brunet; A Defrenne; C Andrieu; K Hacene; A Desplaces; J Rouëssé; H Rochefort
Journal:  Lancet       Date:  1989-11-11       Impact factor: 79.321

3.  Cathepsin-D in human endometrium: induction by progesterone and potential value as a tumor marker.

Authors:  T Maudelonde; P Martinez; J P Brouillet; F Laffargue; A Pages; H Rochefort
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

Review 4.  Gene products which play a role in cancer invasion and metastasis.

Authors:  L A Liotta
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

5.  Cervical carcinoma: a hazard model in early stage disease.

Authors:  R.J. Hale; W.D.J. Ryder; F.L. Wilcox; C.H. Buckley; V.R. Tindall
Journal:  Int J Gynecol Cancer       Date:  1992-03       Impact factor: 3.437

6.  Cathepsins D and E in normal, metaplastic, dysplastic, and carcinomatous gastric tissue: an immunohistochemical study.

Authors:  T Saku; H Sakai; N Tsuda; H Okabe; Y Kato; K Yamamoto
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

7.  [Cathepsin D activity in human ovarian carcinoma].

Authors:  W Reich; F Wagner; K D Hofmann; F Marzotko; G Schmeisser
Journal:  Zentralbl Gynakol       Date:  1984

8.  Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study.

Authors:  J A Henry; A L McCarthy; B Angus; B R Westley; F E May; S Nicholson; J Cairns; A L Harris; C H Horne
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

9.  Structure, function, regulation and clinical significance of the 52K pro-cathepsin D secreted by breast cancer cells.

Authors:  H Rochefort; P Augereau; P Briozzo; F Capony; V Cavailles; G Freiss; M Garcia; T Maudelonde; M Morisset; F Vignon
Journal:  Biochimie       Date:  1988-07       Impact factor: 4.079

10.  Distribution of the Mr 52,000 estrogen-regulated protein in benign breast diseases and other tissues by immunohistochemistry.

Authors:  M Garcia; G Salazar-Retana; A Pages; G Richer; J Domergue; A M Pages; G Cavalie; J M Martin; J L Lamarque; B Pau
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

View more
  1 in total

1.  Immunohistochemical detection of nm23/NDP kinase and cathepsin D in medullary carcinomas of the thyroid gland.

Authors:  R Holm; J Høie; O Kaalhus; J M Nesland
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.